17-39700245-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001382783.1(ERBB2):​c.-209C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000774 in 1,292,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000077 ( 0 hom. )

Consequence

ERBB2
NM_001382783.1 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.279

Publications

0 publications found
Variant links:
Genes affected
ERBB2 (HGNC:3430): (erb-b2 receptor tyrosine kinase 2) This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008]
ERBB2 Gene-Disease associations (from GenCC):
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lung cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glioma susceptibility 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • visceral neuropathy, familial, 2, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BS2
High AC in GnomAdExome4 at 10 Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001382783.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB2
NM_004448.4
MANE Select
c.7C>Tp.Leu3Leu
synonymous
Exon 1 of 27NP_004439.2P04626-1
ERBB2
NM_001382783.1
c.-209C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 28NP_001369712.1P04626-5
ERBB2
NM_001382784.1
c.7C>Tp.Leu3Leu
synonymous
Exon 1 of 28NP_001369713.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ERBB2
ENST00000269571.10
TSL:1 MANE Select
c.7C>Tp.Leu3Leu
synonymous
Exon 1 of 27ENSP00000269571.4P04626-1
ERBB2
ENST00000584450.5
TSL:1
c.7C>Tp.Leu3Leu
synonymous
Exon 1 of 26ENSP00000463714.1J3QLU9
ERBB2
ENST00000578199.5
TSL:1
c.-18+5064C>T
intron
N/AENSP00000462808.1F5H1T4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000774
AC:
10
AN:
1292202
Hom.:
0
Cov.:
31
AF XY:
0.00000629
AC XY:
4
AN XY:
635854
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26264
American (AMR)
AF:
0.00
AC:
0
AN:
23340
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28026
South Asian (SAS)
AF:
0.00
AC:
0
AN:
67344
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3786
European-Non Finnish (NFE)
AF:
0.00000967
AC:
10
AN:
1034428
Other (OTH)
AF:
0.00
AC:
0
AN:
53278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
13
DANN
Benign
0.95
PhyloP100
0.28
PromoterAI
-0.070
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2058005545; hg19: chr17-37856498; API